Livongo to Present at J.P. Morgan 38th Annual Healthcare Conference
December 16, 2019 09:00 ET
|
Livongo Health
MOUNTAIN VIEW, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and...
Livongo Earns Preferred Status on New Express Scripts Digital Health Formulary
December 12, 2019 09:10 ET
|
Livongo Health
Participating health plans and employers can now expand access to Livongo’s leading Diabetes, Hypertension, and Weight Management solutionsLivongo also gains preferred status within the Express...
Livongo Announces Pricing of Public Offering by Selling Stockholders
December 11, 2019 19:42 ET
|
Livongo Health
MOUNTAIN VIEW, Calif., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc. (Nasdaq: LVGO) today announced the pricing of its underwritten public offering of 2,777,327 shares of its common stock...
Livongo to Present at Piper Jaffray 31st Annual Healthcare Conference
November 21, 2019 09:00 ET
|
Livongo Health
MOUNTAIN VIEW, Calif., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and...
Livongo Reports Third Quarter Financial Results
November 06, 2019 16:01 ET
|
Livongo Health
Third quarter Total Revenue of $46.7 million, up 148% year-over-year207,815 enrolled Livongo for Diabetes Members, up 118% year-over-year2019 revenue guidance range raised to between $168.5 million...
Livongo Announces Updated Presentation Time at Credit Suisse 28th Annual Healthcare Conference
October 31, 2019 09:00 ET
|
Livongo Health
MOUNTAIN VIEW, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and...